PHARMAZEUTISCHE FORMULIERUNG
European patent · EP4021405 · Deleted
Register entry
- Publication number
- EP4021405
- Application number
- EP20764963
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Aug 27, 2020
- Published
- Jul 6, 2022
- Granted
- Nov 6, 2024
- Deleted
- Mar 24, 2026
- Reason
- Annual fee unpaid
- IPC classes
- A61K 9/00 (2006.01)A61K 47/02 (2006.01)A61K 47/26 (2006.01)A61K 47/32 (2006.01)A61K 47/36 (2006.01)A61K 47/38 (2006.01)A61K 47/40 (2006.01)A61K 31/135 (2006.01)
- Priority
- GB 201912505 30.08.2019
- PCT application
- PCT/EP2020/073940 27.08.2020
- PCT publication
- WO2021/037960 04.03.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 24, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 24.03.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 24.03.2026
- Sep 17, 2025
Change
Published in Swissreg on 17.09.2025
- Nov 6, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 06.11.2024
Parties
Inventor
BOYER, Scott
754 50 Uppsala, SE
HÜBINETTE, Fredrik
754 50 Uppsala, SE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.